S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Analysts boosted Snowflake stock, big firms are buying now
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
First it was Tyson stock, now this food company is set to rally
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Analysts boosted Snowflake stock, big firms are buying now
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
First it was Tyson stock, now this food company is set to rally
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Analysts boosted Snowflake stock, big firms are buying now
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
First it was Tyson stock, now this food company is set to rally
Block's multiple ecosystems drive shares higher on 2024 outlook
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Analysts boosted Snowflake stock, big firms are buying now
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
6 reasons to buy Teva Pharmaceuticals stock sooner than later
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
First it was Tyson stock, now this food company is set to rally
Block's multiple ecosystems drive shares higher on 2024 outlook
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

$132.03
+0.01 (+0.01%)
(As of 02/23/2024 08:52 PM ET)
Today's Range
$131.57
$133.36
50-Day Range
$128.10
$139.82
52-Week Range
$96.80
$145.43
Volume
1.88 million shs
Average Volume
1.45 million shs
Market Capitalization
$38.69 billion
P/E Ratio
31.36
Dividend Yield
0.71%
Price Target
$137.44

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
4.1% Upside
$137.44 Price Target
Short Interest
Healthy
0.99% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.78
Upright™ Environmental Score
News Sentiment
0.71mentions of Agilent Technologies in the last 14 days
Based on 26 Articles This Week
Insider Trading
Selling Shares
$12.73 M Sold Last Quarter
Proj. Earnings Growth
9.49%
From $5.48 to $6.00 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.35 out of 5 stars

Computer And Technology Sector

124th out of 577 stocks

Analytical Instruments Industry

7th out of 28 stocks


A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Agilent Names Padraig McDonnell as Next CEO
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Agilent Announces Cash Dividend of 23.6 Cents per Share
Agilent Announces Cash Dividend of 23.6 Cents per Share
A Feb 2024 130.000 put
Cognex Corporation (CGNX) Matches Q4 Earnings Estimates
Agilent Ranked Among Top 50 Most Just Companies in America
Agilent to Participate in TD Cowen Health Care Conference
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/20/2023
Ex-Dividend for 1/24 Dividend
12/29/2023
Dividend Payable
1/24/2024
Today
2/25/2024
Next Earnings (Confirmed)
2/27/2024
Ex-Dividend for 4/24 Dividend
4/01/2024
Dividend Payable
4/24/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$137.44
High Stock Price Target
$165.00
Low Stock Price Target
$120.00
Potential Upside/Downside
+4.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
16 Analysts

Profitability

Net Income
$1.24 billion
Pretax Margin
19.60%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.42 per share
Book Value
$19.98 per share

Miscellaneous

Free Float
N/A
Market Cap
$38.69 billion
Optionable
Optionable
Beta
1.11

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Agilent Technologies was last updated on Sunday, February 25, 2024 at 3:51 PM.

Pros

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies, Inc. provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide, indicating a diverse and stable revenue stream.
  • The company has a strong focus on innovation and research, leading to the development of cutting-edge products that cater to evolving market needs.
  • Agilent Technologies, Inc. has a solid financial performance, with consistent revenue growth and profitability, making it an attractive investment option.
  • Recent developments in the company's product portfolio have received positive feedback from customers and industry experts, enhancing its market position.
  • Investors may find the current stock price of Agilent Technologies, Inc. to be undervalued based on its growth potential and financial health.

Cons

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • While the company has a strong market presence, it faces intense competition from other industry players, which could impact its market share and profitability.
  • Agilent Technologies, Inc. operates in a highly regulated industry, subject to changes in government policies and regulations that may affect its operations and financial performance.
  • Fluctuations in raw material prices and currency exchange rates could pose risks to the company's cost structure and margins, impacting its overall financial health.
  • The company's growth prospects may be limited by market saturation or shifts in customer preferences, leading to challenges in sustaining revenue growth over the long term.
  • Investors should carefully consider the overall market conditions and economic outlook before making investment decisions related to Agilent Technologies, Inc. to mitigate potential risks.














A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 6 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

16 analysts have issued 12 month price targets for Agilent Technologies' stock. Their A share price targets range from $120.00 to $165.00. On average, they predict the company's stock price to reach $137.44 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 at the beginning of 2024. Since then, A shares have decreased by 5.0% and is now trading at $132.03.
View the best growth stocks for 2024 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decline in short interest in January. As of January 15th, there was short interest totaling 2,790,000 shares, a decline of 28.5% from the December 31st total of 3,900,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio is presently 1.4 days. Approximately 1.0% of the shares of the stock are short sold.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our A earnings forecast
.

How can I listen to Agilent Technologies' earnings call?

Agilent Technologies will be holding an earnings conference call on Tuesday, February 27th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) posted its quarterly earnings data on Monday, November, 20th. The medical research company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.34 by $0.04. The medical research company earned $1.69 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a trailing twelve-month return on equity of 28.24% and a net margin of 18.15%. Agilent Technologies's revenue for the quarter was down 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.53 earnings per share.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Wednesday, February 21st. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.236 per share on Wednesday, April 24th. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.71%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its board has initiated a stock repurchase plan on Monday, January 9th 2023, which authorizes the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 4.4% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's leadership believes its stock is undervalued.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.63%), Massachusetts Financial Services Co. MA (4.52%), Price T Rowe Associates Inc. MD (2.56%), Northern Trust Corp (1.36%), State Farm Mutual Automobile Insurance Co. (1.31%) and Norges Bank (1.25%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 2/26/2024 by MarketBeat.com Staff